The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.
Boston Scientific recently announced the pricing of a public offering of $750
million aggregate principal amount of its senior notes under the Company's existing
shelf-registration statement. The public offering consists of $400 million of
5.50 percent notes due November 15, 2015 and $350 million of 6.25 percent notes
due November 15, 2035.